Specific objectives
SECONDARY
The primary objective of the study is to determine if adherence to MDR-TB treatment among patients on self-administered therapy (measured by MEMS technology) is non-inferior to that among patients on directly observed therapy (DOT). The secondary objectives of the study include determining the correlation between MDR-TB drug serum concentrations and adherence as measured by MEMS technology and comparing treatment outcomes between MDR-TB patients on self-administered therapy and standard DOT